If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
169.05    -0.95 (-0.56%)
Bid:
169.00
Ask:
169.05
Spread: 0.05 (0.03%)
Market Cap: £7.66b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Trading Update

10 Dec 2024 07:00

RNS Number : 4145P
Centrica PLC
10 December 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. Not for release, publication or distribution in whole or in part, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction

10 December 2024

Centrica plc 

 

Trading Update

 

Centrica plc (the "Company") will be holding a teach-in for institutional investors and analysts on its Centrica Energy and Meter Asset Provider (MAP) businesses at 2.30pm (GMT) this afternoon. A copy of the presentation will be available at www.centrica.com/investors prior to the event. Ahead of that, the Company provides the following update on its trading performance.

 

The Company has delivered good strategic progress in 2024, including announcing the extension of the lives of its four operational Advanced Gas-cooled Reactor ("AGR") nuclear power stations on 4th of December, and solid operating performance across the portfolio.

 

· The Company expects 2024 full year earnings per share to be broadly in line with analyst consensus1.

The usual uncertainties remain for the balance of the year, including weather, commodity prices and asset performance.

In aggregate, adjusted operating profit in Retail and Optimisation is expected to be in line with analyst consensus, including an improved financial result in Services & Solutions compared to 2023.

Infrastructure adjusted operating profit is also expected to be in line with analyst consensus based on year-to-date performance and the outlook for December, including hedging. This includes a second half loss for Centrica Energy Storage+.

2024 full year capital expenditure is expected to be around £600 million.

2024 closing net cash is expected to be in line with analyst consensus1.

· For 2025:

The Company expects all Retail Energy Supply and Optimisation businesses to be in the medium-term sustainable adjusted operating profit ranges.

British Gas Services & Solutions is expected to deliver a further improved financial result compared with 2024, as it continues its recovery towards its medium-term sustainable adjusted operating profit range by 2026.

2025 Infrastructure adjusted operating profit is currently expected to be in the range of £250 million - £400 million, subject to asset performance and commodity prices. This includes an expected adjusted operating loss in the range of £50 million - £100 million for Centrica Energy Storage+.

 

Centrica remains committed to its disciplined capital allocation framework, and is today announcing a £300 million extension to its existing share buyback programme. The extension, once completed, will mean the Company has repurchased £1.5 billion of its ordinary shares since November 2022, representing approximately 20% of the Company's issued share capital. The extension will begin as soon as practically possible and is expected to complete no later than the end of September 2025.

 

 

Enquiries:

Investors and Analysts: tel: +44 (0)1753 494900 email: ir@centrica.com

Media: tel: +44 (0)1784 843000 email: media@centrica.com

 

Notes:

1. As at 9th December 2024, the mean 2024 full year adjusted earnings per share from 11 sell side analyst forecasts published since Centrica's 2024 Interim Results announcement on 25th July 2024 is 18.5 pence, with a mean net cash forecast of £2.56 billion.

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654 Legal Entity Identifier number: E26EDV109X6EEPBKVH76 ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDDBDDDBGDGSC
Date   Source Headline
19th Apr 20236:16 pmRNSTransaction in Own Shares
18th Apr 20236:10 pmRNSTransaction in Own Shares
17th Apr 20236:25 pmRNSTransaction in Own Shares
17th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20234:45 pmRNSHolding(s) in Company
12th Apr 20236:25 pmRNSTransaction in Own Shares
12th Apr 20235:00 pmRNSHolding(s) in Company
12th Apr 20232:45 pmRNSDirector/PDMR Shareholding
11th Apr 20236:25 pmRNSTransaction in Own Shares
6th Apr 20236:30 pmRNSTransaction in Own Shares
6th Apr 20234:30 pmRNSHolding(s) in Company
5th Apr 20236:30 pmRNSTransaction in Own Shares
5th Apr 20232:15 pmRNSHolding(s) in Company
5th Apr 20232:00 pmRNSTransfer of Treasury Shares
5th Apr 20237:00 amRNSCommencement of Share Buy-Back Programme
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20235:30 pmRNSDirector/PDMR Shareholding
29th Mar 20236:25 pmRNSTransaction in Own Shares
28th Mar 20236:25 pmRNSTransaction in Own Shares
27th Mar 20236:20 pmRNSTransaction in Own Shares
27th Mar 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 20236:15 pmRNSTransaction in Own Shares
24th Mar 20235:00 pmRNSHolding(s) in Company
24th Mar 202310:00 amRNSHolding(s) in Company
23rd Mar 20236:00 pmRNSTransaction in Own Shares
22nd Mar 20236:10 pmRNSTransaction in Own Shares
22nd Mar 20233:30 pmRNSDirector/PDMR Shareholding
22nd Mar 202311:19 amRNSAnnual Financial Report 2022
21st Mar 20236:10 pmRNSTransaction in Own Shares
20th Mar 20236:20 pmRNSTransaction in Own Shares
20th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20236:15 pmRNSTransaction in Own Shares
16th Mar 20236:00 pmRNSTransaction in Own Shares
16th Mar 20235:00 pmRNSHolding(s) in Company
15th Mar 20236:25 pmRNSTransaction in Own Shares
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20239:00 amRNSDirector/PDMR Shareholding
14th Mar 20236:20 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSPlans to extend life of two nuclear power stations
13th Mar 20236:25 pmRNSTransaction in Own Shares
13th Mar 20232:00 pmRNSDirector/PDMR Shareholding
10th Mar 20236:15 pmRNSTransaction in Own Shares
10th Mar 20233:45 pmRNSHolding(s) in Company
9th Mar 20236:15 pmRNSTransaction in Own Shares
8th Mar 20236:25 pmRNSTransaction in Own Shares
7th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20234:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.